Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both?

Leukemia. 2021 Dec;35(12):3364-3370. doi: 10.1038/s41375-021-01419-7. Epub 2021 Sep 27.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diagnostic Techniques and Procedures / standards*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Monitoring, Physiologic / standards*
  • Neoplasm, Residual / diagnosis*